Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-4,210
Closed -$1.21M 115
2023
Q4
$1.21M Hold
4,210
0.15% 92
2023
Q3
$1.13M Buy
+4,210
New +$1.05M 0.15% 92
2021
Q1
Sell
-4,080
Closed -$938K 167
2020
Q4
$938K Buy
4,080
+1,740
+74% +$401K 0.14% 78
2020
Q3
$595K Buy
2,340
+10
+0.4% +$2.48K 0.09% 71
2020
Q2
$549K Buy
2,330
+60
+3% +$13.7K 0.09% 80
2020
Q1
$460K Buy
+2,270
New +$496K 0.08% 82

Other funds holding AMGN

Estate Counselors's AMGN Position: Q1 2024 in Review

Estate Counselors sold out of Amgen (AMGN) in Q1 2024, closing a stake of 4,210 shares — an estimated $1.21M sold.

Estate Counselors first reported a position in AMGN in Q1 2020 and held it in 6 quarters. The position peaked at $1.21M in Q4 2023. 2,715 funds tracked by Wall St. Rank hold AMGN as of Q1 2024.

  • Estate Counselors reported no remaining Amgen position as of Q1 2024 after selling out during the quarter.
  • Estate Counselors sold 4,210 Amgen shares in Q1 2024, an estimated $1.21M.
  • Estate Counselors first reported a position in Amgen in Q1 2020 and held it in 6 quarters.
  • Estate Counselors's Amgen position peaked at $1.21M in Q4 2023.
  • 2,715 funds tracked by Wall St. Rank held Amgen as of Q1 2024.

Based on Estate Counselors's 13F filing for Q1 2024, filed 14 May 2024.